combination therapy

Research in Review

Testosterone-Lowering Therapy for Prostate Cancer May Increase Dementia Risk

10/17/2016

JCP Editors

Using testosterone-lowering drugs to treat prostate cancer may make men twice as likely to develop dementia within five years as patients whose testosterone levels were not tampered with, according to a retrospective...

Using...

10/17/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 9-15

10/13/2016

JCP Editors

Which of the following drugs added to adjuvant endocrine therapy helped to reduce the risk for contralateral breast cancer in women with invasive breast...

Which...

10/13/2016

Journal of Clinical Pathways

Department

Cognitive Factors Linked to Treatment Adherence in Elderly Patients With Cancer

10/07/2016

JCP Editors

Cognitive factors such as working memory dysfunction and depression may be predictors of non-adherence in patients with cancer, especially among the elderly, according to a study presented at the European Society for...

...

10/07/2016

Journal of Clinical Pathways

Department

Hypofractionated Radiation Therapy Offers Value-Based Care for Patients With Prostate Cancer

10/04/2016

JCP Editors

In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, treatment with hypofractionated radiation therapy offers similar health-related quality of life (HRQoL) outcomes in...

In the...

10/04/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of Sept 25‚ÄîOct 1

09/29/2016

JCP Editors

Bevacizumab, added to standard adjuvant therapy with capecitabine, offered no benefit to patients with which of the following cancer types? colorectal cancer small cell lung cancer non-small cell lung...

...

09/29/2016

Journal of Clinical Pathways

Research in Review

ALK Inhibitor Treatment Response Better Predicted With Combo Genetic Screening

09/26/2016

JCP Editors

Combining fluorescence in situ hybridization (FISH) analysis and immunohistochemistry (IHC) assays may help to identify rare anaplastic lymphoma kinase (ALK) mutations in patients with non-small cell lung...

...

09/26/2016

Journal of Clinical Pathways

Research in Review

Immunotherapy Plus Chemotherapy Kills More Cancer Cells Than Chemotherapy Alone

09/09/2016

JCP Editors

When chemotherapy alone is used to treat cancer, some dormant cells may survive and become resistant to additional treatment; but, when combined with immunotherapy, the majority of these cells may be destroyed,...

When...

09/09/2016

Journal of Clinical Pathways

Research in Review

More Chemotherapy Does Not Lead to Improved Outcomes for Patients With Osteosarcoma

08/31/2016

JCP Editors

Results from a large clinical trial argue against the inclusion of ifosfamide and etoposide to postoperative chemotherapy in patients with poorly responding osteosarcoma due to increasing toxicity and no improvement...

...

08/31/2016

Journal of Clinical Pathways

Research in Review

Chemotherapy Followed By Surgery Improves Lung Cancer Outcomes Compared With Chemoradiation Alone

07/26/2016

JCP Editors

Preoperative chemotherapy followed by resection may produce better survival outcomes than chemoradiation alone for patients with lung cancer, according to a study published in Medical Science Monitor. Current...

...

07/26/2016

Journal of Clinical Pathways

Research in Review

Adjuvant Chemotherapy Improves Colon Cancer Outcomes

07/22/2016

JCP Editors

Adjuvant chemotherapy may improve survival in patients with stage II colon cancer regardless of treatment regimen, patient age, or high-risk pathologic features, according to a study published in the journal Cancer....

...

07/22/2016

Journal of Clinical Pathways